1. WHO Classification of Tumors Editorial Board. Central nervous System tumors. Lyon (France): International Agency for Research on Cancer; 2021. (WHO Classification of tumors series, 5th ed.; vol. 6).
2. Chen WC, Choudhury A, Youngblood MW, Polley MYC, Lucas CHG, Kanish Mirchia, et al. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nature medicine [Internet]. 2023 Nov 9 [cited 2024 May 27];29(12):3067–76. Available from: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11073469/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11073469/)
3. Alessia Pellerino, Bruno F, Palmiero R, Edoardo Pronello, Bertero L, Riccardo Soffietti, et al. Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? Cancers [Internet]. 2022 Apr 30;14(9):2256–6. Available from: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100910/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100910/)
4. Bakhshinyan D, Suk Y, Kuhlmann L, Adile AA, Vladimir Ignatchenko, Custers S, et al. Dynamic profiling of medulloblastoma surfaceome. Acta neuropathologica communications. 2023 Jul 10;11(1).
5. Ferguson ID, Patiño-Escobar B, Tuomivaara ST, Lin YHT, Nix MA, Leung KK, et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nature Communications [Internet]. 2022 Jul 15 [cited 2023 Jul 9];13(1):4121. Available from: [https://www.nature.com/articles/s41467-022-31810-6](https://www.nature.com/articles/s41467-022-31810-6)
6. Yeung J, Yaghoobi V, Miyagishima D, Vesely MD, Zhang T, Badri T, et al. Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas. Neuro-Oncology [Internet]. 2021 Apr 29 [cited 2022 Oct 27];23(11):1922–35. Available from: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563319/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563319/)
7. Terabe M, Wu J. Rethinking Immunotherapy in Meningiomas. Neuro-Oncology. Volume 23, Issue 11, November 2021, Pages 1812–1813. [https://doi.org/10.1093/neuonc/noab168](https://doi.org/10.1093/neuonc/noab168)
8. Medici G, Freudenmann LK, Velz J, Sophie Shih-Yüng Wang, Konstantina Kapolou, Nagarajan Paramasivam, et al. A T-cell antigen atlas for meningioma: novel options for immunotherapy. Acta neuropathologica. 2023 June 27;146(2):173–90.
9. Pan S, Chen R, Aebersold R, Brentnall TA. Mass Spectrometry Based Glycoproteomics—From a Proteomics Perspective. Molecular & Cellular Proteomics. 2010 Aug 24;10(1):R110.003251.
10. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta (BBA) - General Subjects [Internet]. 1999 Dec 17;1473(1):4–8. Available from: [https://www.sciencedirect.com/science/article/abs/pii/S0304416599001658?via%3Dihub](https://www.sciencedirect.com/science/article/abs/pii/S0304416599001658?via%3Dihub)
11. Justin Z Wang, Alexander P Landry, David R Raleigh, Felix Sahm, Kyle M Walsh, Roland Goldbrunner, Leeor S Yefet, Jörg C Tonn, Chloe Gui, Quinn T Ostrom, Jill Barnholtz-Sloan, Arie Perry, Yosef Ellenbogen, C Oliver Hanemann, Gerhard Jungwirth, Michael D Jenkinson, Ghazaleh Tabatabai, Tiit I Mathiesen, Michael W McDermott, Marcos Tatagiba, Christian la Fougère, Sybren L N Maas, Norbert Galldiks, Nathalie L Albert, Priscilla K Brastianos, Felix Ehret, Giuseppe Minniti, Katrin Lamszus, Franz L Ricklefs, Jens Schittenhelm, Katharine J Drummond, Ian F Dunn, Omar N Pathmanaban, Aaron Cohen-Gadol, Erik P Sulman, Emeline Tabouret, Emelie Le Rhun, Christian Mawrin, Jennifer Moliterno, Michael Weller, Wenya (Linda) Bi, Andrew Gao, Stephen Yip, Maximilian Niyazi, The International Consortium on Meningiomas (ICOM), Kenneth Aldape, Patrick Y Wen, Susan Short, Matthias Preusser, Farshad Nassiri, Gelareh Zadeh, Meningioma: International Consortium on Meningiomas (ICOM) consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patients, Neuro-Oncology, 2024;, noae082. [https://doi.org/10.1093/neuonc/noae082](https://doi.org/10.1093/neuonc/noae082)